Neurobiology of nitrous oxide-induced antinociceptive effects

Molecular Neurobiology

Volumn 25, Issue 2, 2002, Pages 167-189

  Fujinaga, Masahiko ^a,b   Maze, Mervyn ^a,b  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Adrenoceptor; Analgesia; Antinociceptive effect; Descending inhibitory pathway; GABA; Nitrous oxide; Opioid peptides

Indexed keywords

ANTINOCICEPTIVE AGENT; BENZODIAZEPINE RECEPTOR; BETA ENDORPHIN; LEUCINE ENKEPHALIN; METENKEPHALIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITROUS OXIDE; OPIATE PEPTIDE; OPIATE RECEPTOR;

ANALGESIA; ANTINOCICEPTION; ARTICLE; DOPAMINERGIC NERVE CELL; DRUG MECHANISM; HUMAN; NEUROBIOLOGY; NORADRENERGIC NERVE; PERIAQUEDUCTAL GRAY MATTER; SPINAL CORD; STRAIN DIFFERENCE;

EID: 0036128205     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1385/MN:25:2:167     Document Type: Article

References (139)

1. A history of nitrous oxide
2. Physics, chemistry, and manufacture of nitrous oxide
3. Recent advances in understanding the actions and toxicity of nitrous oxide
4. Endogenous pain control mechanisms: Review and hypothesis
5. Endogenous pain control systems: Brainstem spinal pathways and endorphin circuitry
6. Functional characteristics of the midbrain periaqueductal gray
7. Central nervous system mechanisms of pain modulation
8. Enkephalin neurons that project to the A7 catecholamin cell group are located in nuclei that modulate nociception: Ventromedial medulla
9. Projections of neurons in the periaqueductal gray to pontine and medullary catecholamine cell groups involved in the modulation of nociception
10. Topographic organization and neurochemical identity of dorsal raphe neurons that project to the trigeminal somatosensory pathway in the rat
11. The modulation of nociception by enkephalin-containing neurons in the brainstem
12. Nitrous oxide analgesia
13. The analgesia produced by nitrous oxide, ethylene and cyclopropane in the normal human subject
14. Nitrous oxide analgesia: Resemblance to opiate action
15. Nitrous oxide effects on cerebral evoked potential to pain: Partial reversal with a narcotic antagonist
16. Antagonism of nitrous oxide by naloxone in man
17. Nitrous oxide analgesia: Reversal by naloxone and development of tolerance
18. Opiate-like analgesic activity in general anaesthetics
19. Nitrous oxide analgesia. Partial antagonism by naloxone and total reversal after periaqueductal gray lesions in the rat
20. Effect of subtype-selective opioid receptor blockers on nitrous oxide antinociception in rats
21. Antagonism of nitrous oxide antinociception in the rat hot plate test by site-specific mu and epsilon opioid receptor blockage
22. Nitrous oxide induces preemptive analgesia in the rat that is antagonized by halothane
23. Antinociceptive response to nitrous oxide is mediated by supraspinal opiate and spinal α2 adrenergic receptors in the rat
24. The effects of naloxone on the analgesic activities of general anaesthetics
25. Influence of narcotic antagonist drugs upon nitrous oxide analgesia in mice
26. Mediation of nitrous oxide analgesia in mice by spinal and supraspinal κ-opioid receptors
27. Protection by U-50,488H against β-chlornaltrexamine antagonism of nitrous oxide antinociception in mice
28. Dose-dependent antagonism and potentiation of nitrous oxide antinociception by naloxone in mice
29. A study of central opioid receptor involvement in nitrous oxide analgesia in mice
30. Stereospecific reversal of nitrous oxide analgesia by naloxone
31. Naloxone fails to antagonize nitrous oxide analgesia for clinical pain
32. Analgesic and hypnotic effects of subanaesthetic concentrations of xenon in human volunteers: Comparison with nitrous oxide
33. Effects of naloxone on nitrous oxide actions in healthy volunteers
34. A comparative study of the antinociceptive action of xenon and nitrous oxide in rats
35. Central noradrenergic mediation of nitrous oxide-induced analgesia in rats
36. Paradoxical effect of naloxone on nitrous oxide analgesia in man
37. Letter to the editor
38. Pharmacokinetic differences could explain the lack of reversal of nitrous oxide analgesia by low-dose naloxone
39. Failure of naloxone to reverse the nitrous oxide-induced depression of a brain stem reflex: An electrophysiologic and double-blind study in humans
40. Effects of naloxone on the subjective and psychomotor effects of nitrous oxide in humans
41. Naloxone has no effect on nitrous oxide anesthesia
42. Nitrous oxide stimulation of locomotor activity: Evidence for an opiate-like behavioral effect
43. Anesthesia does not increase opioid peptides in cerebrospinal fluid of humans
44. Effects of nitrous oxide exposure on met-enkephalin levels in discrete areas of rat brain
45. Nitrous oxide inhalation does not influence plasma concentrations of β-endorphin or metenkephalin-like immunoreactivity
46. Does nitrous oxide induce release of brain opioid peptides?
47. Influence of nitrous oxide upon regional brain levels of methionine-enkephalin-like immunoreactivity in rats
48. Central β-endorphin release and recovery after exposure to nitrous oxide in rats
49. The effects of nitrous oxide on the central endogenous pro-opiomelanocortin system in the rat
50. The effects of nitrous oxide on the secretory activity of pro-opiomelanocortin peptides from basal hypothalamic cells attached to cytodex beads in a superfusion in vitro system
51. 7 into canine third ventricular cerebrospinal fluid
52. Opiate receptors in the periaqueductal gray mediate analgesic effect of nitrous oxide in rats
53. Effect of opioid peptide antisera on nitrous oxide antinociception in rats
54. Role of brain dynorphin in nitrous oxide antinociception in mice
55. Antagonism of nitrous oxide antinociception in mice by intrathecally administered antisera to endogenous opioid peptides
56. Inhibitors o nitric oxide synthesis antagonize nitrous oxide antinociception in mice and rats
57. Involvement of nitric oxide in intracerebroventricular β-endorphin-induced neuronal release of methionine-enkephalin
58. Involvement of nitric oxide in nitrous oxide anxiolysis in the elevated plus-maze
59. Possible mechanisms of action of nitrous oxide at the opioid receptor
60. Opiate receptor binding studies influence of a reversible sulfhydryl agent
61. Opiate-like analgesic activity in general anaesthetics
62. 3H]Naloxone displacement: Evidence for nitrous oxide as opioid receptor agonist
63. Effects of nitrous oxide and halothane on μ and κ opioid receptors in guinea-pig brain
64. Nitrous oxide activates the supraspinal pain inhibition system
65. Effect of nitrous oxide on spinal dorsal horn WDR neuronal activity in cats
66. Xenon has greater inhibitory effects on spinal dorsal horn neurons than nitrous oxide in spinal cord transected cats
67. The analgesic action of nitrous oxide is dependent on the release of norepinephrine in the dorsal horn of the spinal cord
68. Nitrous oxide analgesia: Existence of acute tolerance and complete antagonism by yohimbine
69. Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of α2B adrenoceptors
70. Neural nuclei activated by nitrous oxide in Fischer rats
71. Effects of halothane and nitrous oxide anaesthesia on 5-HT turn-over in the rat brain
72. Contrasting influences of 5-hydroxytryptamine receptors in nitrous oxide antinociception in mice
73. Serotonergic pontomedullary neurons are not activated by antinociceptive stimulation in the periaqueductal gray
74. Activation of serotonergic neurons in the raphe magnus is not necessary for morphine analgesia
75. Actions of halothane and nitrous oxide on dorsal horn neurons ("The spinal gate")
76. Suppression of impulse transmission in the cat's dorsal horn by inhalation anesthetics
77. Lamina-specific suppression of dorsal horn unit activity by nitrous oxide and by hyperventilation
78. Lamina-specific suppression and acceleration of dorsal-horn unit activity by nitrous oxide: A statistical analysis
79. Effect of nitrous oxide alone or its combination with fentanyl on spinal reflexes in cats
80. Naloxone does not antagonize the anesthetic-induced depression of nociceptor-driven spinal cord response in spinal cats
81. Nitrous oxide decreases somatocardiac sympathetic A-and C-reflexes in anesthetized rats
82. Nitrous oxide produces antinociceptive response via α2B and/or α2C adrenoceptor subtypes in mice
83. Nitrous oxide activates GABAergic neurons in the spinal cord in Fischer rat
84. Bidirectional modulation of nociception by GABA neurons in the dorsolateral pontine tegmentum that tonically inhibit spinally projecting noradrenergic A7 neurons
85. Norepinephrine facilitates inhibitory transmission in substantia gelatinosa of adult rat spinal cord (part 2). Effects on somatodendritic sits of GABAergic neurons
86. Evidence for the involvement of spinal cord alpha-1 adrenoceptors in the antinociceptive effect of nitrous oxide in Fischer rats
87. International union of pharmacology nomenclature of adrenoceptors
88. A point mutation of the alpha 2-adrenoceptor that blocks coupling to potassium but not calcium currents
89. Central hypotensive effects of the α2a-adrenergic receptor subtype
90. Cardiovascular regulation in mice lacking α2-adrenergic receptor subtypes b and c
91. The role of descending noradrenergic and serotonergic pathways in the modulation of nociception: Focus on receptor multiplicity
92. Neurons containing β-endorphin in rat brain exist separately from those containing enkephalin: Immunocytochemical studies
93. In vivo imaging of nitrous oxide-induced changes in cerebral activation during noxious heat stimuli
94. 2O) antinociception
95. Strain-dependent variability in nitrous oxide withdrawal seizure frequency
96. Nitrous oxide antinociception in BXD recombinant inbred mouse strains and identification of quantitative trait loci
97. Strain differences in antinociceptive effect of nitrous oxide on tail flick test in rats
98. Pain during continuous nitrous oxide administration
99. Tolerance to nitrous oxide decreases in volunteers
100. Acute tolerance to nitrous oxide in humans
101. Effects of subanesthetic concentrations of nitrous oxide on cold-pressor pain in humans
102. Differential acute tolerance development to effects of nitrous oxide in humans
103. Tolerance to nitrous oxide analgesia in rats and mice
104. Enkephalinase inhibition prevented tolerance to nitrous oxide analgesia in rat
105. Progressive changes in electroencephalographic responses to nitrous oxide in humans: A possible acute drug tolerance
106. Neural blockade of sleep and anesthesia
107. Effects of nitrous oxide on the epileptogenic property of enflurane in cats
108. Rapidly developing tolerance to acute exposures to anesthetic agents
109. Nitrous oxide-induced hypothermia in the rat: Acute and chronic tolerance
110. Acute tolerance to the analgesic action of nitrous oxide does not develop in rats
111. Dopaminergic reward regions of Lewis and Fischer rats display different levels of tyrosine hydroxylase and other morphine- and cocaine-regulated phosphoproteins
112. Fischer and Lewis rat strains differ in basal levels of neurofilament proteins and their regulation by chronic morphine in the mesolimbic dopamine system
113. Lewis and Fischer rat strains display differences in biochemical, electrophysiological and behavioral parameters: Studies in the nucleus accumbens and locus coeruleus of drug naive and morphine-treated animals
114. Brain dynorphin and enkephalin systems in Fishcer and Lewis rats: Effects of morphine tolerance and withdrawal
115. Relationship between hypothalamic-pituitary-adrenal activity and blockade of tolerance to morphine analgesia by pain: A strain comparison
116. Prolonged exposure to nitrous oxide decreases opiate receptor density in rat brainstem
117. The functional development of descending inhibitory pathways in the dorsolateral funiculus of the newborn rat spinal cord
118. The development of stimulation-produced analgesia (SPA) in the rat
119. Nitrous oxide lacks antinociceptive effect on tail flick test in newborn rats
120. Effect of nitrous oxide on formalin-induced c-Fos expression in the spinal cord of adult and newborn Fischer rats
121. Developmental variation in nitrous oxide induced c-Fos expression in Fischer rat spinal cord
122. Developmental neurobiology of pain in neonatal rats
123. Volatile anaesthetic antagonize nitrous oxide and morphine-induced analgesia in the rat
124. The effects of subanesthetic concentrations of sevoflurane and nitrous oxide, alone and in combination, on analgesia, mood, and psychomotor performance in healthy volunteers
125. Ultrastructural morphometric analysis of enkephalin-immunoreactive terminals in the ventrocaudal periaqueductal gray: Analysis of their relationship to periaqueductal gray-raphe magnus projection neurons
126. The projection of noradrenergic neurons in the A7 catecholamine cell group to the spinal cord in the rat demonstrated by anterograde tracing combined with immunocytochemistry
127. The projections of locus coeruleus neurons o the spinal cord
128. Demonstration of two separate descending noradrenergic pathways to the rat spinal cord: Evidence for an intragriseal trajectory of locus coeruleus axons in the superficial layers of the dorsal horn
129. The noradrenergic innervation of the spinal cord: Differences between two substrains of Sprague-Dawley rats determined using retrograde tracers combined with immunocytochemistry
130. Anatomical evidence for genetic differences in the innervation of the rat spinal cord by noradrenergic locus coeruleus neurons
131. Spinal projections of the locus coeruleus and the nucleus subcoeruleus in the Harlan and the Sasco Sprague-Dawley rat
132. The projections of noradrenergic neurons in the A5 catecholamine cell group to the spinal cord in the rat: Anatomical evidence that A5 neurons modulate nociception
133. Afferent projections to the rat locus coeruleus demonstrated by retrograde and anterograde tracing with cholera-toxin B subunit and Phaseolus Vulgaris leucoagglutinin
134. Role of the locus coeruleus in emotional activation
135. Release of neurotransmitters in the locus coeruleus
136. Descending noradrenergic pathways involved in the A5 depressor response
137. Afferent and efferent connections of the A5 noradrenergic cell group in the rat
138. Ultrastructural analysis of ventrolateral periaqueductal gray projections to the A7 catecholamine cell group
139. Ultrastructural evidence that substance P neurons form synapses with noradrenergic neurons in the A7 catecholamine cell group that modulate nociception